Newly engineered CAR T cells can better discriminate between cancer and normal cells
Tuesday, September 1, 2015 - 10:30
in Physics & Chemistry
A new development in engineering chimeric antigen receptor (CAR) T cells, called affinity tuning, can make the CAR T cells spare normal cells and better recognize and attack cancer cells, which may help lower the toxicity associated with this type of immunotherapy when used against solid tumors, according to a preclinical study.